Le A, Lane AN, Hamaker M, Bose S, Gouw A, Barbi J, et al
On Wednesday, the Food and Drug Administration issued a warning, calling compounded GLP-1 medications "risky for patients." "FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 (glucagon-like peptide-1 (GLP-1) receptor agonists) drugs, including semaglutide and tirzepatide, as an option for weight loss," the FDA said
But the week I started taking the shots, my libido plummeted. It was an odd phenomenon for Shea, who joked that she was once borderline addicted to sex
Haploidentical peripheral blood stem cell transplantation demonstrates stable engraftment in adults with sickle cell disease
Are you maintaining your improvements
Yerushalmi R, Woods R, Ravdin PM, Hayes MM, Gelmon KA